Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 6,124,314

Try a free trial See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,124,314

Title:	Osteoporosis compounds
Abstract:	This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
Inventor(s):	Cameron; Kimberly O. (East Lyme, CT), Lefker; Bruce A. (Gales Ferry, CT), Rosati; Robert L. (Stonington, CT)
Assignee:	Pfizer Inc. (New York, NY)
Application Number:	09/161,797
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,124,314
Patent Claims:	see list of patent claims

Details for Patent 6,124,314

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	➤ Sign Up	Pfizer Inc. (New York, NY)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	➤ Sign Up	Pfizer Inc. (New York, NY)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	➤ Sign Up	Pfizer Inc. (New York, NY)	➤ Sign Up	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Pfizer Inc. (New York, NY)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patent Family for US Patent 6,124,314

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
United States of America	2002165255	Nov 07, 2002
United States of America	6376502	Apr 23, 2002
Japan	H11180926	Jul 06, 1999
European Patent Office	0911321	Apr 28, 1999
European Patent Office	0911321	Jan 31, 2001
Canada	2249867	Apr 10, 1999
Brazil	9804437	May 02, 2001
Country	Patent Number	Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.